FDA Adverse Event Injury Summary report: N

UNKNOWN TRI STAPLE PRODUCT

MDR report key: 9695094 · Received February 11, 2020

Report

Report Number
1219930-2020-00670
Event Type
Injury
Date Received
February 11, 2020
Date of Event
February 2, 2018
Report Date
February 11, 2020
Manufacturer
COVIDIEN LP LLC NORTH HAVEN
Product Code
GDW
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

TITLE: ROBOTIC VERSUS LAPAROSCOPIC DISTAL PANCREATECTOMY: A FRENCH PROSPECTIVE SINGLE-CENTER EXPERIENCE AND COST-EFFECTIVENESS ANALYSIS SOURCE: SPRINGER SCIENCE+BUSINESS MEDIA, LLC, PART OF SPRINGER NATURE 2018, RECEIVED: 15 SEPTEMBER 2017; ACCEPTED: 28 JANUARY 2018; PUBLISHED ONLINE 02 FEBRUARY 2018. (B)(4). IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

ACCORDING TO THE STUDY, THIS IS TO COMPARE THE SHORT-TERM RESULTS OF THE DEVICE IN ROBOTIC DISTAL PANCREATECTOMY AND LAPAROSCOPIC DISTAL PANCREATECTOMY FROM 2011 UNTIL 2016. THE DISTAL PANCREATECTOMY WAS PERFORMED TO 38 PATIENTS, AGES 44-83 YEARS OLD WITH 12 MALES AND 26 FEMALES. IN ROBOTIC DISTAL PANCREATECTOMY, THERE WERE FIVE PATIENTS HAD POSTOPERATIVE COMPLICATIONS. SIX PATIENTS HAD PANCREATIC FISTULA. ONE PATIENT HAD PULMONARY COMPLICATIONS. ONE PATIENT WAS RE-OPERATED WITHIN 90 DAYS. HOWEVER, IN LAPAROSCOPIC DISTAL PANCREATECTOMY, THERE WERE 11 PATIENTS HAD POSTOPERATIVE COMPLICATIONS. 10 PATIENTS HAD PANCREATIC FISTULA. THREE PATIENT HAD PULMONARY COMPLICATIONS. TWO PATIENT WAS READMITTED WITHIN 90 DAYS DUE TO FEVER WITH PERIPANCREATIC FLUID COLLECTION TREATED SUCCESSFULLY BY ANTIBIOTICS. ONE PATIENT WAS RE-OPERATED WITHIN 90 DAYS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
159114 UNKNOWN TRI STAPLE PRODUCT STAPLE, IMPLANTABLE GDW COVIDIEN LP LLC NORTH HAVEN UNKNOWN TRI STAPLE PRODUCT

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention